Holdings (Monthly)
Guide ↗
PGIM Jennison Health Sciences Fund
· Prudential Sector Funds, Inc.| # | Name | Ticker | Since | Shares | Shares Δ | Value | Val Δ% | % Port | Cat |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ELI LILLY & COMPANY | LLY | Feb 2026 | 218,000 | -14,558 | $240.9M | -1.5% | 17.35% | EC |
| 2 | MERCK & COMPANY INC | MRK | Feb 2026 | 708,913 | — | $84.2M | -4.1% | 6.06% | EC |
| 3 | UNITEDHEALTH GROUP INC | UNH | Feb 2026 | 214,171 | — | $81.5M | +29.7% | 5.87% | EC |
| 4 | THERMO FISHER SCIENTIFIC INC | TMO | Feb 2026 | 128,459 | +50,396 | $63.3M | +55.5% | 4.56% | EC |
| 5 | ARGENX SE | ARGX | Feb 2026 | 59,035 | — | $49.4M | +9.0% | 3.55% | EC |
| 6 | VERTEX PHARMACEUTICALS INC | VRTX | Feb 2026 | 104,411 | — | $46.7M | -9.9% | 3.37% | EC |
| 7 | DANAHER CORP | DHR | Feb 2026 | 249,533 | +38,668 | $45.6M | +2.6% | 3.28% | EC |
| 8 | INTUITIVE SURGICAL INC | ISRG | May 2026 | 100,530 | NEW | $42.7M | — | 3.07% | EC |
| 9 | LONZA GROUP AG | LONN | Feb 2026 | 65,672 | -13,376 | $41.9M | +154.6% | 3.02% | EC |
| 10 | CVS HEALTH CORP | CVS | Feb 2026 | 384,647 | -212,703 | $35.0M | -26.7% | 2.52% | EC |
| 11 | (PIPA070) PGIM Core Government Money Market Fund | 74440W862 | May 2026 | 34,655,221 | NEW | $34.7M | — | 2.50% | STIV |
| 12 | INSMED INC | INSM | Feb 2026 | 296,139 | +162,870 | $31.7M | +59.1% | 2.28% | EC |
| 13 | ROIVANT SCIENCES LTD | ROIV | Feb 2026 | 1,022,182 | NEW | $30.7M | — | 2.21% | EC |
| 14 | STRYKER CORP | SYK | May 2026 | 98,162 | NEW | $29.9M | — | 2.16% | EC |
| 15 | SIONNA THERAPEUTICS INC | SION | Feb 2026 | 651,048 | — | $27.9M | +17.2% | 2.01% | EC |
| 16 | BEONE MEDICINES LTD | ONC | Feb 2026 | 87,672 | — | $25.2M | -9.2% | 1.82% | EC |
| 17 | VAXCYTE INC | PCVX | Feb 2026 | 479,492 | +16,403 | $24.6M | -13.8% | 1.77% | EC |
| 18 | ALIGN TECHNOLOGY INC | ALGN | Feb 2026 | 138,932 | +78,019 | $24.3M | +109.9% | 1.75% | EC |
| 19 | AGILENT TECHNOLOGIES INC | A | Feb 2026 | 177,040 | -25,863 | $24.0M | -2.6% | 1.73% | EC |
| 20 | PALVELLA THERAPEUTICS INC | PVLA | Feb 2026 | 183,037 | — | $21.7M | -12.3% | 1.56% | EC |
| 21 | APOGEE THERAPEUTICS INC | APGE | Feb 2026 | 240,387 | — | $19.7M | +17.3% | 1.42% | EC |
| 22 | CABALETTA BIO INC | CABA | Feb 2026 | 4,960,717 | +1,442,615 | $18.8M | +60.5% | 1.35% | EC |
| 23 | PRUDENTIAL INVESTMENT PORTFOLIOS 9 | 74440E300 | Feb 2026 | 18,208,988 | -4,817,556 | $18.2M | -20.9% | 1.31% | STIV |
| 24 | NEWAMSTERDAM PHARMA COMPANY NV | NAMS | Feb 2026 | 534,102 | NEW | $18.0M | — | 1.30% | EC |
| 25 | DIANTHUS THERAPEUTICS INC | DNTH | May 2026 | 190,688 | NEW | $17.7M | — | 1.28% | EC |
| 26 | KYMERA THERAPEUTICS INC | KYMR | Feb 2026 | 215,651 | — | $17.6M | -10.9% | 1.26% | EC |
| 27 | SCHOLAR ROCK HOLDING CORP | SRRK | Feb 2026 | 352,173 | -172,386 | $17.4M | -25.2% | 1.25% | EC |
| 28 | CELCUITY INC | CELC | Feb 2026 | 111,421 | +38,082 | $14.8M | +80.7% | 1.07% | EC |
| 29 | REVOLUTION MEDICINES INC | RVMD | Feb 2026 | 93,878 | -2,996 | $14.8M | +49.6% | 1.06% | EC |
| 30 | ASTRAZENECA PLC | AZN | Feb 2026 | 79,048 | NEW | $14.7M | — | 1.06% | EC |
| 31 | MINERALYS THERAPEUTICS INC | MLYS | Feb 2026 | 459,547 | +55,836 | $14.5M | +22.5% | 1.04% | EC |
| 32 | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Feb 2026 | 394,502 | -441,021 | $13.9M | -50.7% | 1.00% | EC |
| 33 | XENON PHARMACEUTICALS INC | XENE | Feb 2026 | 252,941 | -269,505 | $13.8M | -38.7% | 1.00% | EC |
| 34 | DISC MEDICINE INC | IRON | Feb 2026 | 198,021 | — | $13.8M | +4.4% | 0.99% | EC |
| 35 | PROTAGONIST THERAPEUTICS INC | PTGX | Feb 2026 | 135,272 | — | $13.5M | +8.1% | 0.97% | EC |
| 36 | BAYER AG | BAYN | Feb 2026 | 306,092 | NEW | $13.0M | — | 0.94% | EC |
| 37 | VERADERMICS INC | MANE | May 2026 | 127,683 | NEW | $12.9M | — | 0.93% | EC |
| 38 | TANDEM DIABETES CARE INC | TNDM | Feb 2026 | 680,031 | +183,735 | $11.7M | -6.8% | 0.84% | EC |
| 39 | ERASCA INC | ERAS | May 2026 | 877,992 | NEW | $11.3M | — | 0.81% | EC |
| 40 | CRINETICS PHARMACEUTICALS INC | CRNX | Feb 2026 | 277,429 | -80,104 | $9.9M | -32.9% | 0.71% | EC |
| 41 | TARSUS PHARMACEUTICALS INC | TARS | Feb 2026 | 162,644 | — | $9.7M | -21.3% | 0.70% | EC |
| 42 | IMMUNOVANT INC | IMVT | Feb 2026 | 277,806 | — | $9.3M | +20.1% | 0.67% | EC |
| 43 | AVALYN PHARMA INC | AVLN | May 2026 | 318,463 | NEW | $9.2M | — | 0.66% | EC |
| 44 | OLEMA PHARMACEUTICALS INC | OLMA | Feb 2026 | 662,745 | +318,127 | $8.7M | +4.8% | 0.63% | EC |
| 45 | ELANCO ANIMAL HEALTH INC | ELAN | May 2026 | 358,880 | NEW | $8.6M | — | 0.62% | EC |
| 46 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | Feb 2026 | 391,457 | — | $8.4M | -20.4% | 0.60% | EC |
| 47 | SEAPORT THERAPEUTICS INC | SPTX | May 2026 | 438,754 | NEW | $8.0M | — | 0.57% | EC |
| 48 | ABIVAX SA | ABVX | Feb 2026 | 56,533 | +11,333 | $7.5M | +36.8% | 0.54% | EC |
| 49 | UNIQURE NV | QURE | Feb 2026 | 250,106 | NEW | $7.1M | — | 0.51% | EC |
| 50 | LB PHARMACEUTICALS INC | LBRX | Feb 2026 | 231,150 | — | $6.5M | +16.5% | 0.47% | EC |
| 51 | TYRA BIOSCIENCES INC | TYRA | Feb 2026 | 182,879 | — | $6.1M | +0.3% | 0.44% | EC |
| 52 | ENLIVEN THERAPEUTICS INC | ELVN | May 2026 | 125,639 | NEW | $5.0M | — | 0.36% | EC |
| 53 | SPYRE THERAPEUTICS INC | SYRE | May 2026 | 64,063 | NEW | $4.7M | — | 0.34% | EC |
| 54 | ORUKA THERAPEUTICS INC | ORKA | May 2026 | 76,396 | NEW | $4.5M | — | 0.32% | EC |
| 55 | CABALETTA BIO INC WARRANT | 000000000 | Feb 2026 | 2,139,298 | NEW | $2.7M | — | 0.20% | EC |
| ✕ | Gilead Sciences Inc. | 375558103 | — | 427,773 | SOLD | $63.7M | — | — | — |
| ✕ | Regeneron Pharmaceuticals, Inc. | 75886F107 | — | 57,331 | SOLD | $44.8M | — | — | — |
| ✕ | Edwards Lifesciences Corporation | 28176E108 | — | 263,382 | SOLD | $22.8M | — | — | — |
| ✕ | Viridian Therapeutics Inc | 92790C104 | — | 459,360 | SOLD | $13.5M | — | — | — |
| ✕ | Apellis Pharmaceuticals Inc | 03753U106 | — | 594,859 | SOLD | $12.5M | — | — | — |
| ✕ | Compass Pathways plc | 20451W101 | — | 610,510 | SOLD | $4.2M | — | — | — |